Clinical-stage biotechnology company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Silence Therapeutics plc.
The 1 sources with the most insights about Silence Therapeutics plc on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Experienced a significant rally driven by clinical data reporting and considered a cheap stock with upward momentum.
Experienced a significant rally driven by clinical data reporting and considered a cheap stock with upward momentum.
Other assets that creators frequently mention in the same content as Silence Therapeutics plc.
The most active sources covering Silence Therapeutics plc (SLNS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Silence Therapeutics plc (SLNS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Silence Therapeutics plc (SLNS) most frequently also discuss INTC, MU, APRE, PLTR, KLAC. See the "Discussed alongside" section above for full asset pages.